AzTrials
AzTrials

Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)NCT03949010

Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

A study testing Kinesiotaping with space correction technique, Kinesiotaping with muscle inhibition technique and Home exercise program in people with Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP), run by Dilşad Sindel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
What is being tested?
Kinesiotaping with space correction technique, Kinesiotaping with muscle inhibition technique and Home exercise program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
No sites listed yet
Study dates
Dec 2013to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • being female
  • being aged between 18 and 45 years old
  • not being in menopausal period
  • having pain in upper trapezius region
  • determining a taut band in examination
  • having at least one active TP in this taut band
Show all 10Show fewer
  • the pain produced by palpation of this TP is the pain that the patient complains
  • painfull restriction of cervical lateral flexion
  • having pain score 4 or more according to NRS
  • signing informed consent.

Who cannot join

  • having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity)
  • having any operative history including the head and neck region
  • having a neuromuscular disease
  • having an active rheumatic disease
  • having a systemic disease (diabetes, hypothyroidism, infection, malignancy...)
  • having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...)
Show all 9Show fewer
  • having serious psychological problems (having score of 30 or more from Beck Depression Inventory)
  • being obese (Body Mass Index≥30 kg/m2)
  • having allergy to kinesiotapes

About this study

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.

Read the detailed description

The investigators conducted a prospective, randomized, controlled trial involving 93 female patients with MPS related to upper trapezius TPs and randomized the patients to KT treatment group with space correction technique and home exercise program (KSCT, n=20), KT treatment group with muscle inhibition technique and home exercise program (KMIT, n=24) and control group (CG, n=27) which received home exercise program only. Patients were evaluated by numerical rating scale (NRS) for their average and maximum pain intensity, Turkish version of neck disability index (NDI), and short form-36 (SF-36) scales. Statistical tests were conducted at the 0.05 significance level for all outcome measures.

Being tested
Kinesiotaping with space correction technique, Kinesiotaping with muscle inhibition technique, Home exercise program
Keywords
Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
Medical subject headings
Myofascial Pain Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kinesiotaping with space correction techniqueOther

    Kinesiotaping with space correction technique twice per week for two weeks along with home exercise program

  • Kinesiotaping with muscle inhibition techniqueOther

    Kinesiotaping with muscle inhibition technique twice per week for two weeks along with home exercise program

  • Home exercise programOther

    Home exercise program which consists of stretching exercises towards neck area

Study groups in NCT03949010
Study groupRoleWhat they receive
Kinesiotaping with space correction techniqueExperimentalNot described
Receives: Other: Kinesiotaping with space correction technique; Other: Home exercise program
Kinesiotaping with muscle inhibition techniqueExperimentalNot described
Receives: Other: Kinesiotaping with muscle inhibition technique; Other: Home exercise program
Home exercise programActive comparatorNot described
Receives: Other: Home exercise program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks

    Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity

    Measured: Initial assessment, First week, second week, sixth week

  2. Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Functional status measurement via Neck Disability Index

    Measured: Initial assessment, second week, sixth week

  3. Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Quality of life measurement via Short Form-36

    Measured: Initial assessment, second week, sixth week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2019
  2. Study startDec 2013
  3. Primary completionDec 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03949010
Sponsor's protocol ID
KSCT&KMIT
Status last verified
May 2019
First submitted
10 May 2019
Last updated
16 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Kinesiotaping with space correction technique, Kinesiotaping with muscle inhibition technique and Home exercise program in people with Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP), run by Dilşad Sindel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks (time frame: Initial assessment, First week, second week, sixth week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in